Excitability properties of motor axons in patients with spontaneous motor unit activity

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 1, 2001, Pages 56-64

  Kiernan, M C ^a   Hart, I K ^b   Bostock, H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Cramp; Excitability; Fasciculation; Spontaneous activity

Indexed keywords

POTASSIUM ION;

ACCOMMODATION; ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DEPOLARIZATION; DIAGNOSTIC PROCEDURE; FASCICULATION; FEMALE; HUMAN; HYPERPOLARIZATION; MALE; MOTOR UNIT POTENTIAL; MUSCLE CRAMP; MYOKYMIA; NERVE CELL EXCITABILITY; NERVE ENDING; NERVE STIMULATION; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL;

ADULT; AGED; AXONS; ELECTROMYOGRAPHY; FEMALE; HUMANS; ISAACS SYNDROME; MALE; MIDDLE AGED; MOTOR NEURONS; MUSCLE CRAMP; MUSCLES;

EID: 0035136014     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.1.56     Document Type: Article

References (42)

1. Isaacs H. A syndrome of continuous muscle fibre activity. J Neurol Neurosurg Psychiatry 1961;24:319-25.
2. + channels are implicated in neuromyotonia. Ann Neurol 1997;41:238-46.
3. Maddison P, Newsom-Davis J, Mills KR. Strength-duration properties of peripheral nerve in acquired neuromyotonia. Muscle Nerve 1999;22:823-30.
4. Burke D. Excitability of motor axons in neuromyotonia. Muscle Nerve 1999;22:797-9.
5. Noble D, Stein RB. The threshold conditions for initiation of action potentials by excitable cells. J Physiol (Lond) 1966;187:129-62.
6. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998;21:137-58.
7. Bostock H, Sears TA, Sherratt RM. The spatial distribution of excitability and membrane current in normal and demyelinated mammalian nerve fibres. J Physiol (Lond) 1983; 341:41-58.
8. Bostock H, Rothwell JC. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol (Lond) 1997;498:277-94.
9. + channels of peripheral nerves. Ann Neurol 1995; 38:714-22.
10. Schwarz JR, Reid G, Bostock H. Action potentials and membrane currents in the human node of Ranvier. Pflügers Arch 1995;430:283-92.
11. Röper J, Schwarz JR. Heterogeneous distribution of fast and slow potassium channels in myelinated rat nerve fibres. J Physiol (Lond) 1989;416:93-110.
12. Kiernan MC, Mogyoros I, Burke D. Differences in the recovery of excitability in sensory and motor axons of human median nerve. Brain 1996;119:1099-105.
13. + channel antibody is a cause of nerve hyperexcitabiliry. Clin Neurophysiol 1999;110:5228.
14. Kiernan MC, Burke D, Andersen KV, et al. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000;23:399-409.
15. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaac's syndrome). Report of five cases and literature review. Brain 1993;116:453-69.
16. Tahmouch AJ, Alonso RJ, Tahmouch GP, et al. Crampfasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder. Neurology 1991;41:1021-4.
17. Dalmau J, Gultekin HS, Posner JB. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol 1999;9:275-84.
18. Bostock H. The strength-duration relationship for excitation of myelinated nerve: computed dependence on membrane parameters. J Physiol (Lond) 1983;341:59-74.
19. Bostock H, Bergmans J. Post-tetanic excitability changes and ectopic discharges in a human motor axon. Brain 1994;117:913-28.
20. Mogyoros I, Kiernan MC, Burke D. Strength-duration properties of human peripheral nerve. Brain 1996;119:439-47.
21. Meulstee J, Darbas A, van Doom PA, et al. Decreased electrical excitability of peripheral nerves in demyelinating polyneuropathies. J Neurol Neurosurg Psychiatry 1997;62: 398-400.
22. Pape HC. Queer current and pacemaker: the hyperpolarization-activated cation current in neurons. Annu Rev Physiol 1996;58:299-327.
23. Baker M, Bostock H, Grafe P, et al. Function and distribution of three types of rectifying channel in rat spinal root myelinated axons. J Physiol (Lond) 1987;383:45-67.
24. Bostock H, Baker M. Evidence for two types of potassium channel in human motor axons in vivo. Brain Res 1988;462:354-8.
25. Bostock H, Sharief MK, Reid G, et al. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 1995; 118:217-25.
26. Horn S, Quasthoff S, Grafe P, et al. Abnormal axonal inward rectification in diabetic neuropathy. Muscle Nerve 1996;19: 1268-75.
27. Bostock H. Mechanisms of accommodation and adaptation in myelinated axons. In: Waxman SG, Stys PK, Kocsis JD, eds. The axon. Oxford: Oxford University Press, 1995:311-27.
28. Stöhr M. Activity-dependent variations in threshold and conduction velocity of human sensory fibers. J Neurol Sci 1981;49:47-54.
29. Gilliatt RW, Willison RG. The refractory and supernormal periods of the human median nerve. J Neurol Neurosurg Psychiatry 1963;26:136-47.
30. Guisset M. The recovery of excitability of human sensory nerve fibres following activity. Arch Int Physiol Biochim 1968;76:139-41.
31. Kuwabara S, Cappelen-Smith C, Lin CS, et al. Excitability properties of median and peroneal motor axons. Muscle Nerve 2000;23:1365-73.
32. Mogyoros I, Kiernan MC, Burke D, et al. Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain 1998;121:851-9.
33. Chiu SY, Ritchie JM. Potassium channels in nodal and internodal axonal membrane in mammalian myelinated fibres. Nature 1980;284:170-1.
34. Eng DL, Gordon TR, Kocsis JD, et al. Development of 4-AP and TEA sensitivities in mammalian myelinated nerve fibers. J Neurophysiol 1988;60:2168-79.
35. Yang Q, Kaji R, Hirota N, et al. Effect of maturation on nerve excitability in an experimental model of threshold electrotonus. Muscle Nerve 2000;23:498-506.
36. Deymeer F, Oge AE, Serdaroglu P, et al. The use of botulinum toxin in localizing neuromyotonia to the terminal branches of the peripheral nerve. Muscle Nerve 1998;21: 643-6.
37. Hart IK, Waters C, Newsom-Davis J. Cerebrospinal fluid and serum from acquired neuromyotonia patients seropositive for anti-potassium channel antibodies label dentate nucleus neurons. Ann Neurol 1996;40:554-5.
38. Bergmans J. Repetitive activity induced in single human motor axons: a model for pathological repetitive activity. In: Culp WJ, Ochoa J, eds. Abnormal nerves and muscles as impulse generators. Oxford: Oxford University Press, 1982: 393-118.
39. Hosokawa S, Shinoda H, Sakai T, et al. Electrophysiological study on limb myokymia in three women. J Neurol Neurosurg Psychiatry 1997;50:877-81.
40. Irani PF, Purohit AV, Wadia NH. The syndrome of continuous muscle fiber activity. Acta Neurol Seand 1977;55:273-88.
41. Torbergsen T, Stalberg E, Brautaset NJ. Generator sites for spontaneous activity in neuromyotonia. An EMG study. Electroencephalogr Clin Neurophysiol 1996;101:69-78.
42. Vincent A. Understanding neuromyotonia. Muscle Nerve 2000;23:655-7.